Tag archive for ‘dry eye syndrome’
Koby Yeshayahou On Friday, October 3rd, 2014

Biolight jumps on strong Zacks recommendation

– Zacks cites the company for its technology, products, and meeting its targets.     The share of Bio-Light Israeli Life Sciences Investments Ltd. (TASE:BOLT; Bulletin Board: BLGTY) shot More...

Can-Fite BioPharma

Can-Fite’s CF101 Trial In Dry Eye Syndrome Fails To Meet Endpoints

– Can-Fite CEO Pnina Fishman: The fact that the safety profile of CF101 remains high is encouraging. – CEO Pnina Fishman / Ilan Besor – Can-Fite BioPharma Ltd. ( CANF ) announced today that More...

Jewish Business News Service On Wednesday, November 6th, 2013

CanFite Wins U.S. Patent For The Reduction Of Intraocular Pressure

– Can-Fite BioPharma Ltd. (TASE: CFBI), (OTCQB: CANFY) and its subsidiary, OphthaliX Inc. (OTCQB: OPLI), jointly announced today that the U.S. Patent and Trademark Office granted a U.S. patent More...

Wordpress site Developed by Fixing WordPress Problems